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ABSTRACT
The current study focuses on the psychological effects of statin medications.
Specifically, this study examines the health related beliefs and behaviors that may be
altered by the consumption of this fast acting class of life saving drugs. Although the
statin class of medication generally produces favorable physiological results, as
evidenced by reduced levels of serum cholesterol, and in some case increases in highdensity lipoproteins, the health related belief system and heath related behaviors may
actually be altered in a negative fashion by engendering a sense of overconfidence; this in
tum may alter beliefs and diminish the impOliance of adhering to a healthy diet and
active exercise schedule. Surveys were developed to solicit patient agreement along a
five point Likeli scale. Items were constructed to assess health related beliefs,
medication overconfidence, locus of control, and exercise habits. Sixty-four primary care
patients from Northeastem and Southeastern Pennsylvania were randomly selected to
complete the surveys.
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CHAPTER 1
INTRODUCTION
Unfortunately, or fortunately, depending on one's perspective, the effects of a
fast-paced, technologically advanced, and almost completely automated society have all
but taken over the American landscape. It is a rare event to see a construction site
without the advanced machinery preparing a foundation, factories where assembly lines
are still dominated by humans, or an office building where the staircase is the primary
means of conveyance to higher floors. Although the trades, business, and professional
areas of the American economy have enjoyed considerable teclmological expansion in
conducting everyday business and providing niceties to the working world, it appears
there may be some health-related tradeoffs. Indeed, many of the technological
advancements have made the workplace much safer, healthier, and more efficient for all,
but at what point do we cross the line of balancing necessary human physical activity and
complete automation?
Interestingly, consumers have grown quite accustomed to receiving the benefits of
technology, and have become quite concerned when contractors, business consultants, or
medical professionals peliorm their trades without the use of the latest technology or
state of the art equipment. Some argue that Americans have become so accustomed to
expecting the latest trends in technology, best ergonomics, most sophisticated medical
procedures, and longest acting pain relieving drugs that we may miss the opportunity to
examine critically what these advancements actually replace, negate, or simplify. In
short, many have become, and continue to be, quite dependent on technological and
medical advancements to the extent that other areas of functioning may actually be
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starting to suffer, specifically, the condition of one's physical health and mental well
being. Has technology provided the confidence to overlook completely the simple,
repetitive behaviors and common sense beliefs that may have prevented the onset of
chronic medical conditions? Can dramatically increasing rates of obesity, hypertension,
hypercholesterolemia, and diabetes be the sole effects of an almost completely automated
and technologically advanced society? FUlihermore, have these advances in technology,
pmiicularly in the field of medicine, encouraged a belief system consistent with
overconfident eating habits, poorer participation in health related behaviors such as
exercise, and shoddier health outcomes in general? Advances, including those in
automotive technology, bio-medical science, residential engineering, medicine, surgery,
and business, have provided the population with conveniences and necessities that
dramatically enhance the quality of human life in many ways. Yet the long-term impact
of technology on our health-status, behavior, and belief system celiainly appears to be an
understudied area of concern.
Particularly, advances in medicine and medical technology are generally seen as
very positive contributions to humanity, and it is not the intention of this research to
condemn or appear anti-progressive; rather, the intention is to heighten the level of
awareness with respect to the misplaced positive health-related behaviors and beliefs,
which may be negatively influenced as a result of the availability of medicines and
medical technology.

To illustrate this point further, and begin to frame a conceptual

argument, it is useful to cite the convenience and speed at which fast-food restaurants
serve their drive-thru customers during lunch, some in 90 seconds or less-guaranteed.
Whereas this ability is certainly the product of a great technology serving the demands of
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its culture, one needs to consider the lost or missed opportunities for a variety of simple,
but valuable, human functions. These of course include casual socialization, a much
needed distraction from a stressful work place, simple physical movement like walking
through a parking lot in lieu of drive-thm, or simply having the oppOltunity to eat one's
lunch slowly. Although disparagement is not directed at the fast-food industry, there
does need to be a heightened awareness of current cultural demands and the impact on
psychological and physiological health.
Succumbing to pressures of eating while "on the go" happens to a great number of
Americans, yet one may not recognize the ill affects that these conveniences have on the
human body. Drawing attention to eating while making the moming commute or
grabbing lunch between appointments may not sound like very interesting conversation
requiring much scientific consideration; it simply is not a healthy habit. However, what
does appear to require attention and discussion is the marketing and consumption of
medications such as antacids, gastric acid reducers, antihypertensives, anti-anxiety,
antidepressants, anti-cholesterol, diuretics, and sleep medications. For instance, Richter
(1992) reported the results of a Gallup survey indicating that 44% of all adult Americans
experience heartbum at least once every month, 10% of all adult Americans complain of
acid reflux symptoms weekly and 40% of adult Americans took antacids for symptom
relief; however, only one in four discuss these symptoms with their doctors. Although,
no causal statements between poor eating habits and acid reflux are made here, the sales
trends in medicines used to treat gastroesophageal reflux disorder (GERD) and the
national epidemic of obesity may appear to provide an interesting correlation. Although
the side effects that a technological and turbulent culture has on human health will remain
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theoretically debatable, the ever present and real health-related effects continue to appear
at an alarming rate across the United States.
In the final review of Healthy People 2000, the Center for Disease Control and
Prevention (CDC) reported an estimated 60 million Americans have cardiovascular
disease (CVD) and more than 950,000 die year1y from the condition. This disease alone
accow1ts for approximately 40 percent of all American deaths per year. The CDC also
reports that coronary heart disease and stroke, the two primary conditions of CVD,
account, respectively, for the first and third leading causes of deaths in Americans;
coronary heart disease, alone, accounts for an estimated 12 million cases in the United
States every year. In an attempt to study health problems and move toward healthier
outcomes for Americans, the CDC has prioritized a list of health related issues and
behaviors that currently affect Americans and have specifically developed targeted areas
of priority regarding healthy outcomes. The first priority area targeted for improvement
includes physical activity and fitness. Physical activity and vigorous exercise practiced
on a routine schedule can improve the quality oflife for many, ifnot all, individuals with
health related problems. McGuinnis and Foege (1993) report that 14 percent of all deaths
in the United States were related to diet and activity habits; whereas, Kujala, Kaprio,
Sal11a, and Koskenvuo (1998) conclude that leisure time physical activity is associated
with decreased mOliality, even after genetic and other familial factors were considered.
Additionally, the 1996 Surgeon General's report on Physical Activity and Health clearly
indicates that physical activity has been shown to reduce the risk of developing or dying
from heart disease, diabetes, colon cancer, or hypeliension, also indicating that physical
activity improves mental health as well as the health of muscles, bones, and joints. Quite

Statin Effects 5
simply, the benefits of physical activity cannot be overstated. Physical activity simply
pays very rich dividends and yet Americans seem to be ignoring this life sustaining data.
For example, in related findings, the CDC published an early release of selected estimates
based on data from the 2004 National Health Interview Survey in which trends in health
conditions and health related behaviors were compared from 1997 through 2004. In this
report, the CDC cited an increasing trend in the prevalence of diabetes among adults ages
18 and older from 5.1 % in 1997 to 7.0% in 2004, and an increasing trend in obesity
among adults ages 18 and older from 19.4% in 1997 to 24.5% in 2004. Conversely, the
CDC also reported similar longitudinal type data on health-related behaviors and beliefs,
but with discouraging results. For example the CDC, in an early release estimate,
reported that adults ages 18 and older who engaged in regular leisure time physical
activity actually increased from 29.9% in 1998 to 31.9% in 2000, but did not change
significantly from 2000 to 2003 and actually decreased from 2003 to 2004. Furthermore,
the CDC assessed the perception of individual health status in adults ages 18 and older,
reporting an estimated decrease in the number of adults who reported their health status
as excellent or very good from the years 2001 (68.4%) to 2004 (66.5%). Considering
these statistics and trends in health-related behaviors and health beliefs, and the
increasing trends in CVD, a review is needed to identify the influence of mediating or
moderating variables which may place undue emphasis on clinical interventions while
minimizing the effect of exercise and healthy eating needs. A discussion of these
potential variables and their interaction in patients with hypercholestolemia are discussed
in subsequent sections; this is essentially, in fact, the nature of this research. However, a
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review ofthe basic terminology, course of disease, and clinical interventions will provide
the reader with a more comprehensive understanding of the factors under study.

Hypercholesterolemia
Hypercholesterolemia, simply known as high cholesterol, aflects 18% of
Americans aged 18 to 74; this disease slowly clogs the circulatory system over a lifetime
and directly leads to coronary heal1 disease, the single leading cause of death in the
developed world (Harvard Health Publications, 2005; McGinnis & Foege, 1993).
Vigorous physieal activity and a sensible diet can control and even reverse high
cholesterol without the use of medieal intervention (Shelby, 2005). However, for some
13 million Americans, on cholesterol-lowering medicines, diet and exercise do not appear
to be a reliable treatment option. Thankfully, science has produced very powerful drugs
that can counteract the long-term effects of hypercholesterolemia; therefore, high
cholesterol and CVD become very treatable and preventable medical conditions.
Moreover, the negative effects of arteriosclerosis, a condition directly related to and
caused by high cholesterol, is also reversible (Harvard Health Publication, 2005).
Cholesterol is a fatty, waxy, and naturally occurring substance belonging to a class of
chemicals known as lipids and is an essential energy provider which fuels cells, serves as
a primary building block of cell membranes, is used to make bile acids assisting in the
digestion of food, and also is a very important precursor to vitamin D and hormones,
including estrogen and testosterone (Harvard Health Publications, 2005). Obviously,
cholesterol is very important to the body. Although the liver produces it naturally, alld
cholesterol is naturally absorbed through the intestinal tract, the human body generally
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produces more than an abundant supply. A problem, however, begins to develop when
non-endogenous, or dietary cholesterol, becomes overabundant and upsets the ratio of
lipids throughout the body. That is, cholesterol is classified into several different types,
all with various and distinct influences on the body, Serum cholesterol, or blood
cholesterol, is the total, regulated level of cholesterol available in the blood; a desirable
level of total cholesterol is less than 200mg (Harvard Health Publications, 2005),
Excessive serum cholesterol, and other metabolic debris that is left over after the body
has consumed a sufficient amount of essential nutrients, travels through the vast network
of arterial vessels throughout all regions of the body, The circulatory system is the
distribution system for the transportation of lipids throughout the body. Although the
bloodstream is an efficient delivery system for many types of nutrients, for compounds,
and of course for oxygen; before some compOlmds can be transp0l1ed via the
bloodstream they must be packaged and prepared for circulation. Because cholesterol is
a lipid, or fat, dumping it directly in the bloodstream would cause it to congeal and form
unusable and dangerous clots. Therefore, in order for cholesterol to be transp0l1ed
effectively, it must be molecularly wrapped in proteins. The lipids, now wrapped in
proteins, form tiny particles called lipoproteins. Although the bloodstream carries many
types of lipoproteins, when it concerns heart disease the most imp0l1ant lipoproteins
include high-density lipoproteins (HDL), low-density lipoproteins (LDL), and very-Iowdensity lipoproteins (VLDL) (Harvard Heath Publications, 2005). Each ofthese
lipoprotein substanees has very different effeets on the body. For example, LDLs may
come from two sources, genetic heritage and dietary habits, but regardless of their
origins, excessive LDLs become problematic and dangerous to the circulatory system.
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That is, after a substantial amount of time, excessive pressme in the bloodstream, or
exposme to toxic agents such as nicotine, homocysteine, or excessive blood sugar, the
circulatory system may sustain "nicks" or small abrasions on the inner smooth lining of
vessel walls. In a natural process, the body attempts to repair these "nicks" with LDL's ;
in turn, excessive repairs of "nicks" trigger more LDLs needed to repair, thereby causing
an overabundance of "repair" lipids over a "nick", ultimately creating a plaque build-up,
obstructing blood flow leading to cardiovascular and cerebrovascular disease.
Conversely, as LDL's contribute to arteriosclerosis, HDLs provide a collection function,
"picking-up" other fatty substances, such as LDL's and VLDL's and move them through
the bloodstream to the liver and intestine, places where lipids are disposed.
Understanding the process of aIieriosclerosis and eventual CVD is by no means simple or
uncomplicated. However, George, Kong, Thoman, and Stewart (2005) concluded that
knowledge of the disease process, among other factors, is optimal for treatment
adherence in patients with chronic obstructive pulmonary disease (COPD). Therefore
patient education becomes an important primary prevention factor in helping promote
medication adherence and overall healthy patient outcomes. Yet, the apparent
physiological dichotomy of average American citizens' trend toward increasing rates
obesity and CVD is the leading cause of death in Americans.

Statin Therapy
As the pharmaceutical industry continues to advance the science, technology, and
variety of treatments used to control high cholesterol, Americans are in fact enjoying
longer life spans and improved quality of living. In particular, powerful cholesterol-
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lowering drugs called reductase inhibitors, or commonly called statins, are continuing to
show promising evidence against the ill effects of high cholesterol (Harvard Health
Publications,2005). Current research also reveals an arterial anti-inflammatory function,
antioxidant effects, and an anti-carcinogenic function in animal models, in addition to an
impressive cholesterol-lowering function of the statin class of medications (Davigon &
Laaksonen, 1999). To date there are five well-known, brand-name statin medications on
the market used to remediate hypercholesterolemia (Harvard Health Publications, 2005).
Zocor, Crestor, Lipitor, Vytorin, and Provachol vary in their chemical compounding, but
essentially provide the same effects on the hml1an body. The statin drugs work, in pal1,
by increasing the absorption rate of low-density lipoproteins (LDL's) by the liver as it
filters blood, and these generally are well tolerated in lal'ge clinical trials (Tomlinson,
Chan, & Lall, 2001). Although some fortunate people have been endowed with naturally
low levels ofLDL's, and sufficiently high levels ofHDL's, others have to maintain a
vigil over the types of foods consumed and the amounts of exercise practiced throughout
the week. When considering how one becomes diagnosed with hypercholesterolemia,
two critical factors are important to consider. Genetics and healthy behavior are two of
the most influential val'iables associated with the development of high cholesterol
(Harvard Health Publications, 2005). Although the treatment for inheritable high
cholesterol is primarily medication, with adjunctive exercise and proper diet, patients
with non-inheritable high cholesterol are initially and strongly encouraged to initiate
treatment with dietary and lifestyle modifications. Shelby (2005) reports that aggressive
dietary changes can lower the lipid profile more than 30% by consuming a diet high in
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sterols, high in soluble fiber, and coupled with the consumption of less than 200
milligrams of cholesterol daily.
To date, there is little in the literature with regard to the psychological effects of
the cholesterol lowering drugs called statins. Although not all cardiac related drugs
wan-ant such study, the statin class medications are an interesting group because they are,
in part, prescribed as preventative and prophylactic against coronary artery disease
(CAD) and cerebral infarct (stroke) (Davigon and Laaksonen, 1999). Additionally, statin
medications are well known to the public, with an estimated 50 million patients on statin
therapy; this class of dmgs is one of the most frequently prescribed in America today
(Harvard Health Publications, 2005). As a point of interest, although statin medications
have become very popular, the rates of obesity in middle aged adults, young adults, and
children have also significantly increased over the past several years (CDC, 2004).
Further, despite well published guidelines by the American Heali Association regarding
healthy eating, the average American consumes, in a conservative estimate, 256
milligrams of cholesterol a day, which is 20% over the amount suggested for a healthy
lifestyle (Shelby, 2005). Given the over-consumption of cholesterol laden food items, the
lack of diet adherence in general, and the propensity for a sedentary lifestyle, it would
appear logical that Americans are exposing themselves to early mOliality. An argument
can easily be made that, as a possible result of medical and pharmaceuticals teclmology,
Americans may be paying less and less attention to their diet and exercise habits and
becoming more and more reliant on the use of statin medication to control the effects of
poor dining choices and sedentary lifestyles. However, it may be unfair to critize all as
simply making bad choices; as mentioned previously, not all cholesterol comes entirely
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from food sources. In fact, the human body would create more than enough cholesterol,
even if none were obtained from diet (Harvard Health Publications, 2005).
Davigon and Laaksonen (1999) have provided additional evidence to suggest that,
in addition to their low-density-lipoprotein lowering effects, statin medication have other
beneficial effects including anti-inflammatory properties, antioxidant effects,
anticarcinogenic effects in animals, anticoagulant effects, stabilization of atherosclerotic
plaques, and inhibition of graft rejection after heali and kidney transplantation. With
fmiher promising research to come, even suggesting even that statins remove plaque
build-up on alierial walls thereby reversing CVD, and providing a minimal blood
thinning action, it would appear that several patients and physicians will gain even
greater confidence and have much to celebrate regarding this remarkable class of drugs;
this may lead to higher levels of over-confident eating.

Diet, Exercise, and Health Beliefs
With seemingly effortless access to fast food, generally poor eating habits, and an
increasing sedentary lifestyle, the American popUlation is ripe for a variety of primary
health concems, including hypercholesterolemia, diabetes, and hypeliension. The
amount, and the availability of fast food is certainly not the primary reason so many
Americans have, or will develop, hypercholesterolmia, hypeliension, or diabetes;
however, the American diet in general, the attitude toward exercise and physical activity,
portion regulation, eating habits, health care beliefs, stress management skills, and beliefs
around the effectiveness and protectiveness of cardiac and anti-hypertensive medicines
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must be investigated further to determine what influence, if any, these variables have on
positive health behaviors and healthy outcomes.
The National Institute of Health Technology Assessment Conference reports that
one-quaI1er of Americans me overweight; as many as 40% of women and 24% percent of
men are trying to lose weight at any given time; moreover, many have tried diet, exercise,
behavior modification, as well as the use of drugs to achieve their goals. Yet, the NIH
also reports that, in controlled settings, participants who remained in weight loss
programs generally lost 10% of their weight; however, a disappointing one-third to twothirds of their weight was regained within one yem and nearly all the weight was
regained within five years. CUlTently, obesity has become an epidemic problem in
American culture, with the ill-effects being suffered across all racial divisions, and age
groups-especially children. For example, Popkin and Udry (1998) reported a sample of
third generation American children of various ethnic backgrounds including Anglo,
African-American, Hispanic, and Asian-American adolescents; in their sample of 13,783,
the authors fotmd that 26.5% were obese, and of this sample the majority of obese
children were black non-Hispanics, followed by Hispanics, white non-Hispanics, and last,
Asian American adolescents. Furthermore, Popkin and Udry (1998) rep0l1 that in all
ethnic groups obesity was more prevalent in males than in females and Asian-American
and Hispanic adolescents born in the U.S. were more than twice as likely to be obese than
were first generation residents. To illustrate further the obesity epidemic in the United
States, Allison, Fontaine, Manson, Stevens, Vanltallie (1999) report the estimated
number of annual deaths directly attributable to obesity in 1991 was 325,000. Kujala,
Kaprio, Sarna, and Koskenvuo (1998), however, rep0l1 diet and exercise habits can, and
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do, dramatically improve longevity and the quality oflife for many. Although not all
individuals who are obese ultimately suffer cardiac events directly related to poor diets,
the data regarding current rates of obesity and the mOliality rates due to obesity are
discouraging, and appear to reflect a negative change in the American cultural approach
to diet and exercise. However, it is impOliant to mention that not all cases of
hypercholesterolemia are related to the lack of exercise. For example, Halverstadt,
Phraes, Ferrell, Wilund, Goldberg, and Hagberg (2003) report that HDL levels are an
important risk factor for cardiovascular disease that may be modified through exercise
training; however, the levels ofHDLs, and subfractions thereof, are highly variable
among individuals, suggesting the response to exercise training may also be influenced
by significant genetic variation and the interaction of genetic variation with physical
activity. Although most, ifnot all health care providers will generally agree that routine
exercise simply pays rich health dividends, not all obese or overweight individuals are
solely interested in the health-related effects of exercise. The current struggle with weight
loss, diet adherence, and exercise routines are common topics of conversation among
many; however, not all individuals are losing and maintaining a healthy weight for the
right reasons.

Campos, Saguy, Ernsberger, Oliver, and Gaesser (2006) report the

current diversity of cultural and ideological factors as driving the current, world-wide
obsession with thinness, especially for young women and girls who have tendencies to
demonize celiain foods, as well as the development of heavier bodies, in the spirit of
fashion and cultural trends.
Although there is overwhelming evidence to suggest that smoking habits,
excessive alcohol consumption, diet, and rates of physical activity are impOliant
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determinants of CHD, the complex interactions between diet, lifestyle and lipoprotein
metabolism collectively detennine the eventual development of arteriosclerosis and
related cardiac complications (Kromhout, Menotti, Kesteloot, and Sans, 2002). Yet other
authors have argued that weight control should not be the primary targets when helping
patients avoid CHD. For instance, Campos, Saguy, Ernsberger, Oliver, and Gaesser
(2006), contend that too many obesity researchers, diet researchers, and clinicians believe
that the only point of a healthy lifestyle is simply to make people thin, or to keep them
from getting fat Conversely, the need to maintain healthy and protective lipid proflles is
generally the first strategy in helping patients achieve healthy outcomes. To this end, a
balanced, but varied diet, rich in fiber, fruits, vegetables, and antioxidants, as well as
heart protective omega-3 oils should be the focus of lifestyle and belief changes.
Although any reader can find these healthy suggestions, and much more, in a wide
variety of general periodicals, in health related magazines, and in physician education
brochures, the American public, as well as American physicians, are continually
bombarded with trendy advertisements stressing the importance of discussing the
potential benefits of new medications.
At a cursory review, it appears that Americans greatly value the efficacious
results that powerful medications have on a myriad of medical conditions which, if not
treated, can lead to life-threatening physiological disease and profound psychological
distress. By simply picking up any common periodical and perusing the contents, the
health care priorities of the American public become very clear. That is, the American
culture appears to be a medicine-seeking popUlation. For instance, the American
Academy of Physicians Assistants report that in 2005, physician assistants alone wrote
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278,000,000 prescriptions. This statistic indicates an increase of more that 26 million
prescriptions from 2004. Interestingly, Calandra (2001) repOlis that over the past decade,
health club memberships have increased by only one-third to approximately 30 million
total members throughout the United States. These trends in prescription-seeking and in
exercise habits suggest a greater need for expedient medical treatment and less concem
for lifestyle modification. The sheer number of medication advertisements and the
attractive manner in which they are adveliised can provide any casual reader or television
viewer with a reasonable amount of evidence for the value Americans place on
medications. In fact, most pharmaceutical adveliisements provide a simplified symptom
checklist, on which potential patients, or more accurately, consumers are asked to
endorse the presence, or absence, of certain symptoms. This advertising process may
minimize, or negate the need for patients to manage their diabetes, hype11ension, or
hypercholesterolemia with lifestyle modification, namely diet and exercise, while
concomitantly undermining the physician's role as educator. With a patient-driven
healthcare market, it is apparent that the phmmaceutical industry maintains successful
marketing programs, which are directly targeting patient populations. Additionally,
patients are provided with enough information about the helpful effects of prescription
dmgs while simultaneously emphasizing the current debilitating effects of their unique
disease states, that a state of anxiety occurs and energizes their prescription seeking
behavior and their beliefs that medication is the most time sensitive and efficacious
treatment option. Yet the literature regarding the efficacy of diet and exercise habits in
treating primary health conditions and the ill effects of a sedentary lifestyle is very well
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established (Shelby, 2005; McGuinnis & Foege, 1993; Kujala, Kaprio, Sarna, &
Koskenvuo, 1998).
The current study is important because health-related beliefs and health-related
behaviors are becoming increasingly important factors when considering the potential
mediating or moderating variables that may drive patients' chief complaints, treatment
adherence, or medication reliance. For example, a review of the literature on diabetes
management suggests levels of noncompliance with treatment is related to an individual's
personal health belief model, and to prejudgment by health care professionals about what
patients can accomplish, based on their age, education, or socioeconomic status; this may
lead to negative outcomes (Leichter, 2005). Additionally, noncompliance with
medication regimes among patients with bipolar disorder reveals rates of noncompliance
as high as 64%; knowledge of the factors associated with noncompliance would enhance
clinical management and help patients achieve positive outcomes (Colom, Vieta,
Maliinez-Aran, Reinares, BenabalTe, & Gasto, 2000). As such, a reasonable argument
can be made for patients who medicate on cholesterol lowering drugs. Specifically, it is
desirable to study the psychological effects that statin medications have on patients'
belief systems. Initially, some fundamental questions al'e raised. For example, does
taking statin medicine enhance a patient's overconfident eating behavior after he or she
begins the regime alld is able observe how quickly positive effects are obtained?
Similarly, does taking the medicine foster an overconfident belief in the medicine's
protective value, thereby reducing the perceived need to paliicipate in routine exercise
programs and to reduce sedentary lifestyle? The answer to these questions will yield
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imp0l1ant conclusions, impacting the patient's quality of life, his or her belief system, as
well as a physician's prescribing behavior and role as educator.

Health Belief Model and Social Learning Theory
As a mediating or moderating variable that potentially influences a person's
belief system, the Health Belief Model (HBM) can have long reaching influences on
health and behavior. An entire discipline of clinical psychology has been dedicated to the
investigation, understanding, and remediation of illogical, even unhealthy beliefs. The
study of Social Learning and Cognitive Therapy, with pm1icular influence from the
HBM, can provide the necessary cognitive framework when considering potential
mediating or moderating variables, which may ultimately influence a person's health
related outcomes. Although the strength and salience of an individual's belief system
originate from a variety of sources, cognitive therapists suggest that core beliefs, or
schema, are developed over the course of an individual's lifetime and are influenced by
environmental, cultural, and personal variables including fmnity and social history,
reinforcement histories, education, temperament, intelligence, socio-economic status, and
even religious practices (Freeman, Pretzer, Fleming, & Simon, 1990). In attempting to
understand how cognitive and behavioral variables influence beliefs associated with
health maintenance and disease prevention, a review of the major conceptual models will
provide a more specific foundation of knowledge in understanding what motivates some
persons to adhere to medical regimes, participate in healthy diets, practice regular
exercise, regulate overconfidence, and maintain overall healthy outcomes.
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The HBM is a conceptual system for helping to understand, explain, and predict
preventative health behaviors (Janz & Becker, 1984). The HBM otTers five descriptive
areas which are believed to influence health beliefs and behavior: 1) the individual's
perceived susceptibility to illness, 2) the perceived seriousness of the disease, 3) the
perceived benefits of taking action, 4) barriers interfering with action, 5) cues to taking
action, and self-efficacy; these are the major tenets that frame the HBM (Wiebe and
Christensen, 1997). Investigating individuals' beliefs according to these major domains
will yield patients' conceptualization of their conditions, as well as their resources to
cope with, and take action against the diseases or predict how patients maintain healthy
beliefs and behaviors. The HBM has been applied to a variety of chronic medical
conditions. For example, Patino, Sanchez, Eidson and Delmater (2005), have applied the
HBM to a sample of minority adolescents with type I diabetes and concluded that
evidence was provided to suggest that youth with type I diabetes mellitus reported greater
short-term health risks, compared to longer-term risks, but perceived less risk to
themselves as compared to others. Although the study did not provide support for the
HBM's predicting regimen adherence, the application of the HBM is nevertheless helpful
in gaining a preliminary understanding about the reasons why some patients hold
pa11icular belief systems that may be counterproductive to healthy outcomes. Similarly,
George, Kong, Thoman, and Stewat1 (2005) concluded that health beliefs, knowledge
about and faith in the treatment, routinization of drug therapy, knowledge and acceptance
of the disease process and recommended course of treatment are critical variables for
optimal adherence in patients with chronic obstlUctive pulmonary disease (COPD).
Although many attempts have been made to understand the theoretical reasons for non-
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adherence, the mainstay of several studies has been isolated to specific clinical
populations and has examined specific factors including patient intelligence, familial
support, socioeconomic status, patient education, dosing effects, and physician/patient
interaction, to cite only a few. Although the influence of these variables cannot be
overstated, George, Kong, Thoman, and Stewart (2005) also report patient education
directed at focusing on the course of the disease, as well as education regarding the need
for long-term treatment may help improve patient adherence; yet the authors also report
patients may be likely to alter the recommended course of management, based on how
they feel and believe, especially if the disease is relatively symptomatic as is the case for
COPD.
Similar in some respects to the HBM, Social learning theory suggests that the
social environment is a significant source of behavior cues providing the impetus for
influence over human behavior. Baranowski, Perry, and Parcel (1997) suggest that a
systematic review of the relevant enviromnental constructs associated with nonadherence, places health care providers in an advantageous position to facilitate positive
patient outcomes and discourage unhealthy outcomes. For example, individual
components of Social Learning Theory; including environment, expectation, self-control,
and reinforcement, among other components, suggest that patients will not actively
engage in healthy outcomes if they do not expect the outcome to be successful; therefore,
engendering a sense of self-efficacy becomes a primary factor in facilitating positive
patient outcomes (Glanz, Lewis, & Rimer, 1990).
Another model for predicting healthy patient outcomes involves a review of SelfRegulation Theory. Leventhal, (1984) suggests that a patient's adherence to any

Statin Effects 20
treatment regime is intimately connected with the manifestation of physical symptoms
and illness memories, thereby mediating the compliance process. For instance, a clear
example of Self-Regulation Theory can be found in a review of kidney transplant patients
studied by Siegal and Greenstein (1998). In their study, the authors repOlied patients
were most likely to adhere to their treatment regimes when they were convinced that their
medications must never be missed, their medications' effects are no longer effective after
a day, and physical symptoms interfered with the activities they needed to complete.
Conversely, partial compliers were not likely to believe that the medication was essential,
that the therapeutic half-life was greater, and that their physical symptoms were
considered milder when compared with the previous group.

Biopsychosocial Model
In order to assess any health-related question properly, a belief in, and practice of
the biopsychosocial model provides one of the most comprehensive traditions to
conceptualize a patient's presenting problem(s). Stedman's medical dictionary defines
the biopsychosocialmodel as a conceptual model, which assumes that the psychological
and social factors must also be included along with the biological factors in
understanding an individual's medical illness or disorder. In assessing and treating for
healthy patient outcomes, the biopsychosocial model mandates that patients undergo
assessment(s) that are multifaceted and interdisciplinary, covering various disciplines that
review individual factors specific to each area of expertise. This level of integration
allows for comprehensive review of all systems that may play roles in disease
manifestation, maintenance, and recovery. Conversely, the traditional biomedical model
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postulates a conceptualization that excludes psychological and social forces in patient
assessment and diagnosis, whereas the biopsychosocial model is more comprehensive
and punctuates the importance of individual psychological and social differences. In
studying the psychological, social, and behavioral effects of hypercholesterolemia, diet
and exercise adherence, and providing overconfident beliefs about cholesterol-lowering
medicine's effects on healthy behavior, the value of endorsing the biopsychosocial model
cannot be overstated. That is, because high cholesterol cannot be attributed solely to
genetic factors, the psychological, behavioral, and social influences of practicing routine
exercise, consistently maintaining a healthy diet, and also practicing effective strcss
management, such as controlling anger, maintaining good sleep hygiene, and scheduling
routine relaxation time, become increasingly important in understanding how patients
develop high levels of cholesterol, maintain the integrity of their treatment regimes, or
prn1icipate in rehabilitative and preventative health measures. Concomitantly,
understanding the micro and macro-social forces impacting on a patient's level of
functioning is also critical in the biopsychosocial review of each patient's individual
medical and psychological history. For instance, as the American culture becomes
increasingly time-sensitive, goal-focused, and achievement-oriented, understanding and
incorporating of the social influences of behavior, such as emotional stress, pollution,
over-crowding, normative social influence of dieting and exercise, infol111ational social
influence of medications, private acceptance, conformity, personal sleep habits, and the
human body's response to long term adaptation to stressors must be considered in the
holistic assessment of each patient.
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As a part of the greater ecological systems, and perhaps one of the most
influential detenninants of human behavior, the socially mediated forces that impact upon
a patient's healthy or unhealthy outcomes includes the ever present economic market in
which they currently function. As pharmaceutical companies continue to implement the
very effective direct-to-consumer adveliisements (DTCA), the medical marketplace
continues to be shaped by the sheer power and wealth that the pharmaceutical industry
brandishes over consumers, prescribers, and legislators, using their very sophisticated and
indulgent marketing campaigns in a fashion, ultimately, most advantageous to their own
endeavors. For instance, Donohue and Berndt, (2004) repOlied that spending on DTCA
increased from $266 million in 1994 to $2.6 billion in 2002, making this form of
phmmaceutical marketing the object of substantial controversy. Rosenthal, Brendt,
Donahue, Epstein, and Frank (2003) have additionally repOlied in a study, that the effects
of DTCA accOlUlted for 12% of the increase in prescription drug sales between 1999 and
2000. Consequently, an argument can be made for the development of overconfident
belief systems that are essentially developed out of, and maintained by the propagation of
a seemingly endless banage of medication cOlmnercials and adveliisements, by treatment
programs, and by favorable prognosis as proliferated by the DTCA campaigns. In fact,
Mintzes Barer, Kravitz, Bassett, Lexchin, Kazanjian, Evans, Pan, and Marion (2003)
concluded that more adveliising leads directly to more requests for adveliised medicines
and more prescriptions in general; fUlihermore, the authors contend that if DCTA is
brought into a conversation between patients and physicians, that conversation is quit
likely to end with a prescription, often despite the physician ambivalence about treatment
choice.
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It is important to understand that most if not all pharmaceutical companies

practice this strategy as a marketing and sales tool in attempts to gain the greater market
share for their products. That is, the influence DCTA campaigns on patients, the social,
professional pressure to physicians, and tangible reinforcers that physicians receive on an
almost daily basis may actually serve to entice patients to ask for the most welladvertised medication and for the physicians to actually prescribe the most sought after
medications. Lacasse and Leo (2005), in the case of antidepressant medications and the
controversial serotonin hypothesis, maintain that DTCA campaigns are seductive to
physicians and patients because patients who present with a "chemical imbalance" and
are convinced that they are suffering from a neurotransmitter deficiency are most likely
to seek a prescription for an antidepressant and they may be skeptical of physicians who
suggest other interventions such as cognitive-behavior therapy. Nevertheless, the social
messages embedded in some DCTA campaigns speak directly to patient consumers by
suggesting the disease is predominantly caused by genetic inheritance with little
influence from environmental or behavioral factors. Upon careful review of these
campaigns, one can hear the bias toward the genetic inheritance of disease, thus
assuaging the guilt of patients for not practicing exercise habits of healthy eating. Either
directly or indirectly, the large and wealthy phannaceutical industry is shaping the
relevant health beliefs and behaviors of many American patients and possibly of
physicians. A review of other industrialized countries may provide interesting social
correlations, especially when considering countries with advanced economies such as
Asia and countries of the European Union.
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Possessing an understanding of the biopsychosocial factors that influence high
cholesterol can fmiher help physicians to educate and treat their patients in a number of
ways. The information and data revealed in the Cl1nent study can assist physicians in
understanding the nature of a patient's treatment adherence according to the influential
and ever present biopsychosocial factors. Moreover, conceptualizing the whole patient
from this perspective will provide suggestions of possible treatment barriers or of
facilitators acting upon the patient, suggesting data for, or against, the likelihood that
patients will, or will not, become over-confident regarding the effects of their
medications, violate their dietary plans, or fail to practice cardiovascular exercise
routinely. Similarly, patients can also benefit from lmderstanding their own
biopsychosocial conceptualizations by improving their self-awareness regarding the
behavioral and social factors that influence healthy or unhealthy behaviors. For instance,
patients on cholesterol-lowering medicines can discover particular behavioral habits that
may be unhealthy but are very consistent v'lith their cunent social or work environments.
They can also discover a particular cognitive susceptibility to health related beliefs, such
as over-confident eating, or the influence of social learning on health maintenance habits.
An example may include the DTCA campaigns providing the socialleaming
oppOliunities to create a minimization or rationalization effect, thereby undennining the
importance of diet and exercise adherence. To illustrate fmiher the impOliance ofthe
various biopsychosocial factors, Peyrot, McMurry, and KlUger (1999) found an
interaction between biologic and psychological factors, with psychosocial factors
accounting for more variance in glycemic control within Type 1 Diabetic patients; the
authors found that stable psychosocial resources (i.e., education, being married, and
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positive coping styles) were associated with better chronic glycemic control, but chronic
stress and regimen nonadherence were associated with worse transient glycemic control.
Similarly, a conceptualization from the biopsychosocial model provided evidence that
elderly individuals are at an increased risk for CVD, especially if they are un-paI1nered,
socially isolated, depressed, and report a poorer quality of life (Stuart-Shor, Buselli,
Canoll, & Fonnan, 2003).

Overconfidence
An argument can be made that widespread technology, regardless of the field,
may make consumers feel secure, comfortable, brave, lazy, entitled, or even
overconfident. As the pharmaceutical industry continues to research and develop new
drugs designed to promote wellness, cure diseases, and reverse debilitating conditions,
some investigation seems necessary regarding the cognitive effects of such medical
advancements. That is, do medicines mediate or moderate psychological belief systems
related to health and wellness, prevention and cure, or even diet and exercise habits? In
particular, the present study is designed to investigate the psychological effects that
cholesterol-lowering drugs have on healthy patient outcomes. The need to study the
psychological, specifically cognitive and behavioral effects of this class of medications is
punctuated by their ever-growing popularity. As a construct, overconfidence suggests
that an individual seems to believe that their reasoning processes, belief systems, and
subsequent conclusions are just fine the way they are, and there is no need to take
remedial action in the way they think or act (Aronson, Wilson, & Akert, 2005).

Statin Effects 26
AdherencelNon-adherence and Locus of Control

There are indications that health beliefs are significant predictors of adherence;
specifically, the perceived threat of an illness as a health related belief has received
widespread attention in the literature regarding treatment compliance and adherence
(Carpenter, 2005). In the previous section, the role of overconfidence was reviewed, and
was hypothesized as having an impact on the influence that statin medications have on
healthy patient outcomes. Whether a patient adheres or does not adhere to his or her
treatment regimen appears to be in some fashion related to overconfidence, and as
Carpenter (2005) describes, it is also significantly related to the construct of perceived
threat. That is, the motivation for any individual patient to non-adhere to a treatment
protocol will be complex and interconnected with biological factors including the
treatment's physiological effects, social factors including the ease, costs, and availability
of prescribed treatments, and psychological variables including an individual's beliefs,
about illness; these factors, however, may be central in the prediction of adherence to
diet, exercise, and medication regimens. In particular, then, the current study suggests
that there is a level of overconfidence which may develop because patients on statin
therapy may be more likely to develop beliefs which are consistent with the notion that
they are completely, or mostly, protected from future cerebrovascular or cardiac events.
To fmiher substantiate this claim, the psychological construct of perceived threat could
also be likened to a patient's locus of controL Locus of control refers to a learning
process during which individuals develop a belief system whereby they believe, or
predict, that certain outcomes are a result of their action (internals) or a result of other
forces independent ofthemselves (externals) (Rotter, 1954). Essentially, understanding
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patients' locus of control is helpful regarding their levels of perceived control of their
illness and environmental demands. Similarly, the construct of Health Locus of Control
was also derived from Social Learning Theory and developed out of Rotter's original
work in 1954. However, Wallston, and Wallston (1978) recognized that there was
difficulty in predicting health behavior specifically from generalized expectancy
measures such as Rotter's scale. Moreover, Wallston and Walston (1978) also
discovered through observations of recently diagnosed diabetic patients and their families
that medical staff continued to stress the importance of the patient's active role in his or
her own health care. It was clear, based on their efforts that the medical staff was trying
to establish an internal locus of control in this patient population in anticipation of
facilitating treatment adherence and positive outcomes. Through this observation,
Wallston and Wallston (1978) developed the Health Locus of Control Scale (HLC), a
scale similar to Rotter's original InternaVExternal Locus of Control Scale, but with
specific application and item content unique to health care situations. The HLC scale is
recommended in conjunction with behavioral measures to evaluate health education
programs. Because it appears that individuals with higher levels of internal locus of
control appear more likely to engage in positive health related behaviors and fewer nonadherent behaviors, it is evident that the Health Locus of Control accentuates the
significance of physicians as an educators, endorsing also the need to involve themselves
in training patients to hold more intemal beliefs (Wallston & Wallston 1981). Thus
patients would apparently be more likely to adhere to medical treatments, to low fat diets,
and to exercise regimens if they perceived their behavior did in fact demonstrate causal
relationships with positive and healthy outcomes; also included would be the physicians'
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reinforcement of this belief. However, for some patients, the possibility of experiencing
positive reinforcement, in this case healthy outcomes, as a result of their own healthy
habits including exercise, dieting, or medication adherence may be too temporally and
spatially discontiguous to affect their healthy behavior practices positively. For instance,
Weiner (1986) suggests that Attribution Theory also provides a basis for understanding
the human desire to assign attribution or causality to particular events in their lives when
they are spatially and temporally contiguous. Additionally, Byrns (2000) studied thc low
back pain of factory workers and concluded that employees who attributed pain to
internal constructs including knowledge of back safety, for instance, had a tendency to
experience less distress as compared with those who assigned external attributions. Last,
the Protection Motivation Theory proposed by Rogers suggests that the value of fear
coupled with communication and self-efficacy may lead to the motivation necessary for
developing coping mechanisms such as positive, health-related behaviors. Ultimately,
determining what facilitates or inhibits patients from adhering to prescribed courses of
treatment is as individual and lmique as the patients themselves. The theories described
above, provide a preliminary review ofthe potential mechanisms which may energize
non-adherence.

Rationale
After direct observation and interaction with several individuals receiving statin
therapy for hypercholesterolemia, a common pattern of behavior and a common theme of
beliefs became ever present. That is, pursuant to these observations and interactions,
individuals who were currently receiving statin therapy were feeling apparently more
confident, less guilty, generally less concerned about indulging in overeating, making
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poor diet choices, skipping exercise sessions; they also verbalized the belief that statin
medications protected them from all the consequences associated with overeating, poor
dieting, and lack of, or diminished, exercise routine. Although this observation was
indeed casual and involved only a few individuals, these observations and interactions
did energize curiosity and the desire to study this phenomenon under more controlled and
efficacious conditions. To illustrate this point further, during the course of interaction,
the majority of these individuals, both males and some females, rcported less concem
about eating a high fat lunch or dinner because they were now on a "cholesterol
medicine," and some even reported they could "not worry as much" as they had, prior to
taking the medicine, because the medicine controlled their high cholesterol so effectively
and efficiently that they felt comfortable indulging. Fmiher discussion revealed that
individual exercise habits and general non-adherence to diet were perceived to be equally
less impOliant, and were frequently and routinely violated. For instance, some repOlied
beliefs of failure because exercise and diet regime did not significantly lower cholesterol,
indicating that some individuals were genetically predisposed to have elevated
cholesterol; others held beliefs of frustration, indicating difficult exclusionary diets and a
strenuous exercise program lowered cholesterol levels only incrementally, yet low doses
of statin medication lowered cholesterol levels much more significantly and in a quicker
amount oftime. Interestingly, the individuals who felt fmstrated by the notion that the
statinl11edication worked so well and so easily versus the need to change their lifestyles,
including diet and exercise habits, felt more confident, by individual repOli, to eat
anything and in any amount they desired.
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It was this level of casual discussion, observation, and questioning that provided

the impetus for the current research. Several research questions began to arise and the
aspiration to investigate overconfident beliefs and subsequent unhealthy eating behaviors
became apparent. Although the select few idiosyncratic observations and interactions
may undeniably represent a skewed sample of the statin-taking population, it neveI1heless
provides a rationale to study the phenomenon in a systematic and objective manner.

Purpose of Study
The purpose of the CUlTent study is to examine the psychological and behavioral
concomitants that statin medications have on patients' eating habits, levels of
overconfidence regarding diet non-adherence and exercise non-adherence, and their
overconfident beliefs in the protective value of statin medications. Essentially, the
central purpose of the present study is to identify relationships, if any, between the
behavioral action of routinely taking cholesterol-lowering medication and the health
related beliefs and behaviors which may be negatively altered to produce poor health
outcomes pursuant to ingesting medication on a routine basis. The exact purpose of the
study is not to review the powerful influence of placebos, nor to question the
effectiveness of the statin family of medicines; however, the psychological influences,
both behavioral and cognitive correlates, of consuming a statin drug on a regular regime
is a worthwhile research endeavor by itself.
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Research Questions and Hypotheses
The research questions for this study were based on presumptions that patients
who medicate on cholesterol-lowering agents, specifically statin medications, are
susceptible to beliefs that motivate overconfident eating behaviors, diet and exercise nonadherence, as well as substantiating overconfident beliefs in the protective value of statin
therapy. In general, the hypotheses of this study purport that individuals who manage
their hypercholesterolemia tlu'ough statin therapy will be likely to develop beliefs and
behaviors that are consistent with unhealthy levels of overconfident eating, of diet and
exercise non-adherence, and of overconfident beliefs in the medications' protective value.
Specifically then, five hypotheses were separated and developed. They are as follows:
Question 1: Is it accurate to suggest that among patients receiving statin therapy, the
medication will successfully reduce levels of cholesterol from pre-medication levels, yet
others anlong these patients will not respond positively to statin therapy?
Hypothesis 1: Not all individuals taking statin therapy for hypercholoestermia will
effectively lower and manage their high cholesterol due to other factors which mediate or
moderate counterproductive unhealthy outcomes.
Question 2: Will those patients whose cholesterol is significantly reduced by the effects
of medication, endorse a level of agreement on statements that suggest diminished levels
of exercise from pre- to post-medication time periods?
Hypothesis 2: Patients who have reportedly improved their levels of cholesterol will be
likely to engage in less freqllent exercise.
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Question 3: Will those patients whose cholesterol is significantly reduced by the effects
of medication endorse a level of agreement on statements that suggest diminished levels
of diet adherence from pre- to post-medication time periods?
Hypothesis 3: Patients who have rep0l1edly improved their levels of cholesterol will be
likely to engage in less frequent diet adherence.
Question 4: Will those patients, whose cholesterol is significantly reduced by the effects
of medication, possess over-confident beliefs about the protectiveness oftheir statin
medication?
Hypothesis 4: Patients on statin therapy with improved levels of cholesterol will possess
levels of overconfident belief regarding the medications protectiveness.
~==~

Will beliefs about the causes of high cholesterol be related to diet and

exercise non-adherence and medication overconfidence?
Hypothesis 5: Beliefs and knowledge about the causes of high cholesterol are related to
exercise non-adherence, diet non-adherence, and medication overconfidence.
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CHAPTER 2
METHODOLOGY
Participants
The paIiicipants for this study were randomly selected from a population of
primary care patients receiving care from their primary care physicians' offices in eight
locations. The primaI'y care practices were located in Northeastern and Southeastern
Pennsylvania; one practice was located in New York. Either male or female participants
of any racial background who were above 18 yeal'S of age, with a diagnosis of
hypercholesterolemia (high cholesterol) were able to pal'ticipate in this study. The
completed questionnaires of 64 participants with a diagnosis of hypercholesterolemia,
who were receiving statin therapy, were included as analyzed data sets. PaIiicipants not
diagnosed with hypercholesterolemia and/or younger than 18 years of age were excluded
from the study. Partieipants were advised of their right to not participate in the study, as
well as their right to withdraw from the study at any point in time. Participants were also
required to read and comprehend the English language.
Paliicipants were not required to sign an informed consent form, because no
personally identifiable information was asked, recorded or otherwise collected.
However, a letter of solicitation was attached as a cover letter identifying the
investigators, their contact infOlTIlation, as well as the contact information ofPCOM's
Institutional Review Board. There were no personal identifiers that could provide
evidenee for tracking a paI'ticipant's endorsements on the collected surveys. Participants
who were eligible for the inclusionaI), criteria were asked ifthey would be willing to
participate in a research study designed to study the psychological effects of cholesterol
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medication; they were asked to endorse their levels of agreement on a survey specific to
the design and intention of the study.

Design
The current study uses various statistical methods including anovas, reliability
coefficients, and descriptive statistics. Additionally, c011'elation measures are used to
assess the degrees of relationships, if any, between numbers of different demographic
factors and respondent's health related behaviors. The above mentioned statistical tests
were engaged to determine the statistical properties between various factors, including
health related beliefs specific to diet non-adherence, to medication overconfidence, and to
exercise non"adherence. The demographic data described in the descriptive statistics
consist of age, sex, medication dosage, length of time on medication, type of medication,
frequency of exercise habits, and knowledge regarding disease and preventative care.

Description of Instruments and Measures
A 22 item demographic survey, and a 45 item survey of health-related beliefs and
behaviors was constructed to solicit the levels of agreement that participants had on
statements regarding several health-related beliefs and behaviors, including dietary
habits, exercise habits, knowledge and beliefs about high cholesterol, locus of control,
knowledge and beliefs about medication, knowledge and beliefs about the influence of
exercise and diet on high cholesterol, basic demographic information, and a selection of
statements determining the levels of beliefs and frequency of health-related behavior,
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before and during statin therapy. The statements have been developed by the author and
designed to provide an indication of agreement along a five-point Likert scale.

Procedures
Creation of Packets

The measures were developed, assembled into identical packets (Appendix A),
and were introduced with a brief solicitation letter (Appendix B) indicating the names of
the researchers, a brief narrative describing the nature of the study, how to contact the
researchers in the event that any questions arose, the right to discontinue at any point,
detailed instructions about how to complete the surveys and an approximation of the
length of time it would take to complete the surveys. The infOlmation contained in the
cover letter was presented to the subject in language that was devoid of technical jargon.
Each packet, including all forms within each packet, was numbered Icoded to ensure, that
in the event a packet became disassembled, the researchers could match corresponding
forms accordingly. Again, the study did not require the participant to provide any
personally identifiable infOlmation on any forms or to any researcher directly. There
were a total of 100 packets assembled; there was a response of 64 completed surveys.

Survey Development

The investigators developed the surveys for this study with careful and
comprehensive consideration fi'om the relevant literature. Statements were designed to
elicit a level of agreement along a five point Likert scale. In all, 42 statements were
generated and each statement was fit into a specific subscale being studied. For example,
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the purposes of this study were to reveal relationships between and among the
consumption of stat in medication, overconfidence, and diet and exercise non-adherence;
therefore, statements were constructed to solicit feedback along each of these factors.
Surveys were also checked for ease of understanding, relevance, and content validity by a
panel of fourth year graduate students in the context of a research methods class, by the
Director of Research in Clinical Psychology at Philadelphia College of Osteopathic
Medicine, and by the Chairperson of this research project. All comments and suggestions
for change were carefully considered and the surveys were adjusted and revised when
necessary.

Site Selection
Site selection was dete11nined by the willingness of the primary care physician to
have his or her patients become available to volunteer in this study. The primary care
practices previously listed were verbally solicited by investigators to determine their
willingness to participate in the study. Physicians in private practices, group practices, or
hospital-affiliated practices were advised to consult their individual institutional review
boards, if necessary, and info11n investigators of any additional institutional review board
requirements. Ultimately, none of the sites had additional institutional review board
requirements.

Participant Recruitment
Once the study officially began, a researcher personally delivered the packets to
the sites and provided info11nation and training on the distribution ofpackets to patients.
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One primary care nurse or receptionist at each site was identified as the distributor and
collector of the completed packets. The manner in which the packets were assembled
and constructed allowed for an entirely self-explanatory completion of the packet and
required little or no interaction from the distributor. To recruit participants, the
distributor asked all patients who presented to the primary care practice over a 10-day
period to participate in a research study investigating the psychological effects of
cholesterol medication and health-related beliefs. The distributor also indicated to the
patient the survey would take approximately 15-20 minutes to complete; that it would
contain no items that would identify any personal information, and that the patient could
discontinue the survey at any point without any consequence to his or her care. If the
patient agreed to participate in the study, the distributor handed the patient a complete
packet, asking him or her to read the directions carefully, fill out the survey completely,
and hand it back into the distributor when completed. This process continued until 64
different patients, henceforth referenced as participants, had completed the surveys.
After 64 individual surveys were completed the data collection phase ofthe study was
complete and no further direct interaction with participants occurred.

Data EntlY, Statistical Analysis and Data Reporting
Raw data compiled from completed surveys was coded, and for some items, was
reverse scored, and initially entered into a Mircrosoft Excel spreadsheet for visual
inspection and ease in the data management. Subsequently, the coded data were
imported into the Statistical Program for the Social Sciences (SPSS, Version 14.0) for
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psychometric analysis. Descriptive and inferential statistics were conducted, results
analyzed, graphically displayed and reported.
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CHAPTER 3
RESULTS
This study was eonducted over a one year period, from November, 2006 through
November,2007. A total of 64 paliicipants completed the necessary questionnaires for
this study. In order to fulfill the inclusion criteria, all participants were randomly selected
from a population of primary care patients diagnosed with high cholesterol, who were
cunent1y taking a statin medication to control high levels of cholesterol. Overall,61
(95.3%) of the paIiicipants were diagnosed with high cholesterol and taking a statin
medication. The remaining three participants either did not answer the questions
assoeiated with diagnosis or were not taking statin medicine. Participation in this study
was completely voluntary and each paliicipant completed a survey that did not reveal any
personal identifying information. Additionally, data collected on the surveys eould not
be tracked to individual paIiicipants. A signature verifying informed consent was not
required because no personally identifying inforIllation was collected. However,

ail

introduction letter describing the nature, scope, and potential risks, was attached to each
survey packet and included the researcher's contact infol1natiol1 (appendix A).
Participants could freely remove themselves from this study at anytime with absolutely
no negative influence to their care. All participants were over the age of 18.

Responses to the Survey of Health-Related Beliefs and Behaviors
The Survey of Health-Related Beliefs and Behaviors is a 45 item self-repOli
survey which provides a series of statements whereby participants are asked to rate their
levels of agreement on a five point Likeli scale, in which one (1) represents disagree; two
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(2) represents somewhat disagree; three (3) represents neutral or unsure; four (4)
represents somewhat agree and five (5) represents agree (Appendix C). The 45 items on
the survey were broken down and classified into subscales. Specifically, subscales were
developed to assess levels of agreement with each of the following constructs:
medication-overconfidence protection, diet non-adherence after medication, diet nonadherence before medication, exercise adherence before medication, and exercise
adherence before medication (see tables 1-5). As a subscale, medication-overconfidence
protection was developed to detelmine if a subject was likely to have an elevated sense of
confidence in their medication's protectiveness against fiuther increasing levels of
cholesterol produced by dietary habits (Cronbach's Alpha = .782). The subscale, diet
non-adherence before medication involved a set of variables developed to detelmine the
level of a subject's dietary habits before initiation of his or her current medication
regime (Cronbach's Alpha

.748). Diet non-adherence after medication included

statements designed to solicit a subject's agreement on dietary attitudes and behaviors
after medication was dispensed and taken (Cronbach's Alpha

.435). Last, exercise non-

adherence before and after medication, both of which were single items, were developed
to solicit agreement on a subject's level of cardiovascular exercise prior to struting
medication and during his or her current comse of statin medication. The exercise
subscales were developed as single items; therefore, reliability coefficients were not
possible.

In addition, pru1icipants were asked to complete a brief demographic survey
(appendix B) consisting of20 items which requested participants to indicate their ages,
races, length of time on cholesterol medication, recent changes in dosage, frequency of
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exercise, cunent height, current weight, low-fat diet adherence, medication name,
medication dosage, physician satisfaction with cholesterol levels, and questions related to
health care knowledge. The following tables, graphs, and discussion represent the final
results and provide descriptive statistics, correlations and anovas for the hypotheses of
this study.

Table 1
Variables by Subscale

Overconfidence

1.

Since I've been taking cholesterol-lowering medicine, I can eat anything I
want.

3. I believe my cholesterol-lowering medicine, without diet and exercise,
completely protects me from developing higher cholesterol levels.
5.

Since I have been taking cholesterol-lowering medicine, I feel less worried
about choosing what I eat.

9. Taking cholesterol-lowering medicine regularly is more impOliant than
maintaining a healthy diet.
10. Taking cholesterol-lowering medicine regularly is more impOliant than exercise.
11. Because I take cholesterol-lowering medicine I can eat "fast food" 2 or more
times a week.
15. I trust that the cholesterol-lowering medicine I am taking will effectively lower
my cholesterol without diet and exercise.
16. If my cholesterol level continues to remain high while on cholesterol-lowering
medicine, I can have my dosage increased and continue eating any of the foods
choose.
21. Taking cholesterol-lowering medicine allows me to occasionally eat fattening
food and over indulge.
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Table 2
Variables by Subscale

Diet Non~Adherence after Medication

8. Before I began taking cholesterol-lowering medicine, I ate "red" meat more than
twice a week.
18. Before I began taking cholesterol-lowering medicine, I ate more than 3 servings
of dairy product daily.
26. Before I began taking cholesterol-lowering medicine, I ate "fast food" 2 or more
times a week.
27. Before I began taking cholesterol-lowering medicine, I ate more than 5 servings
of fruits and vegetables daily.
29. Before I began taking cholesterol-lowering medicine, I was not worried about my
diet.
31. Before I began taking cholesterol-lowering medicine, I watched the portion size
of my food servings.

Table 3
Variables by Subscale

Diet Non-Adherence before Medication

6. Since I have been taking the cholesterol-lowering medicine, I eat "red" meat
more than twice a week.
7. Since I have been taking cholesterol-lowering medicine, I eat more than three
servings of dairy products daily.
19. Currently, I eat five or more servings of fiuits and vegetables daily.
28. Currently, I eat "red" meat more than twice a week.
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Table 4
Variables by Subscale

Exercise Adherence before Medication

30. Before I began taking cholesterol-lowering medicine, I practiced cardiovascular
exercise 3 times a week (for at least 30 minutes) or more.

Table 5
Variables by Subscale

Exercise Adherence after Medication

12. Since I have been taking cholesterol-lowering medicine, I practice
cardiovascular exercise 3 times a weck or more.

Descriptive Statistics
Of the 64 participants who voluntarily completed surveys for this study, 24
participants were males (37.5%) and 40 were females (62.5%) (Figure 1). A total of 51
(79.7%) p31iicipants were White, eight (12.5%) were Black, 3 (4.7%) were Hispanic, and
two (3.1 %) were Asian. None of the p31iicipants described himself or herself as "other"
(Figure 2).

Regarding age, the largest group of participants, 19 in total (29.7%)

indicated they were between the ages of 46-55. The second largest group, 14 (21.9%)
participants, repOlied they were between the ages of 56-65. The third largest group of
participants with regard to age consisted of the 13 (20.3%) participants who repOlied their
ages as 36-45. The respective age ranges of the remaining participants consisted of 12
(18.8%), who repOlied their ages as 66 or older, 3 (4.7%) 26-35, and 3 (4.7%), who
repOlied their ages as 18-25 years old (Figure 3). A significant number of participants,
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27 (42.2%), reported taking statin medication(s) for a period of 2-4 years, with the second
largest group, 23 (35.9%), who indicated a period of one year or less on statin
medication(s) (Figure 4).

Sex

Male

Figure 1. Nmnber of participants by sex.
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Figure 4 represents the length of time on medication; it shows the greater number
of participants, 27 (42.2%), reported taking a statin medication for a period of two
through four years, and the second largest group, 23 (35.9%) of the pmiicipants reported
taking a statin medication for a time period of one year or less. The third largest group, 6
(9.4%) ofpaliicipmlts repOlied having been on medicine for a time period of five through
seven years, with the fewest number of participants, 2 (3.1 %) reportedly have taken statin
medication for a period of 8 through ten years. Four participants (6.3%) did not select a
time frmlle, and one respondent repOlied having taken statin medication for a period of
twelve years.
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Figure 4. Number of participants by length of time on medication.
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Figure 5 displays the frequency of weekly exercise sessions indicated by
participants, with the largest groups represented in the following categories, 18 (28.1 %)
"I rarely practice cardiovascular exercise," and 18 (28.1 %) repOlted "less than three time
weekly." Fifteen (23.4%) ofthe pmticipants reported, that they exercised "more than
three times weekly," and 13 (20.3%) who responded as "3 times weekly."

Frequency of Exercise
20

< 3x wkly

3xwkly

> 3xwkly

Rarely practice

Weekly Exercise Sessions

Figure 5. Number of paliicipants by number of weekly exercise sessions: greater than
three times weekly; tIu'ee times weekly; less than three times weekly; rarely practice
cardiovascular exercise.
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Body Mass Index
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Figure 6. Number of participants classified by Body Mass Index (BMI).

According the Body Mass Index (BMI), 23 (35.9%) of participants were
classified as overweight or obese. The remaining 17 (26.6%) were classified as being of
n01111al weight. One respondent did not provide his or her height and weight, therefore
BMI was not able to be calculated.
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Dietary Habits
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Figure 7. Number of participants by self-rating of integrity of dietary habits. Key:
Honest Follow a low-fat diet daily and honestly; Cheat = follow a low-fat diet, but
sometimes I cheat; D/U I do not usually follow a low-fat diet; D/K = I do not know
what a low-fat diet is,

As illustrated in figure 7, 42 (65.6%) of the participants indicated: "Sometimes I
cheat," with 15 (23.4%) who reported they "don't usually follow," and 6 (9.4%)
participants indicated they follow a low fat diet "daily and honestly." Only one
participant did not know what a low-fat diet was.
Most pmiicipants reported knowing the ill effects of untreated cholesterol. Sixtyone (95.3%) reported untreated cholesterol is likely to lead to a heali attack and/or stroke.
Regarding the pmiicipants' knowledge of the origins of cholesterol, Figure 8 represents
the following: 44 (68.8%) repOlied cholesterol comes from "all of the above"; 8 (12.5%)
repOlied cholesterol comes from "food"; 5 (7.8%) repOlied cholesterol is the product of
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"genetics," and 1 (1.6%) reported high cholesterol results from "too little exercise." Six
participants did not respond.
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Figure 8. Knowledge about the origins of cholesteroL
Regarding cholesterol levels, 43(73.4%) of participants indicated their cholesterol
levels improved as a result of medication; 12(18.8%) reported their cholesterol levels
stayed the same or worsened (Figure 9). Seventeen (26.6%) indicated their dosage was
increased; 37 (57.8%) reported their dosage "stayed the same," and 5 (7.8%) indicated
their dosage decreased (Figure 10). Figure 11 illustrates the number of pmiicipants by
milligram of dosage.
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Figure 9. Change in cholesterol levels. W/SS indicates cholesterol levels have worsened
or stayed the same.
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Figure 10. Change in medication dosage.
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Figure 11. Number of participants by medication dosage.
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Hypothesis # 1
It was predicted that not all individuals receiving statin therapy for

hypercholesterolemia will effectively lower and manage their high cholesterol due to
other factor, which may involve behavioral correlates, including exercise non-adherence
and diet non-adherence as well as cognitive correlates, including an overconfident belief
in the medication's protectiveness. Although data indicate that 47 (73.4%) pmiicipants
repOlied improvement in their cholesterol levels, 12 (18.8%) pmiicipants reported their
cholesterol levels stayed the same or actually worsened during their course of stain
therapy. Interestingly, 17 (26.6%) pmiicipants repOlied their physicians have increased
their doses of medication, and 37 (57.8%) indicated their physicians have not changed the
dosage of their medications. Last, only 5 (7.8%) participants indicated that their
physicians have actually decreased their dosage of medication.
Hypothesis # 2
It was predicted that participants who have effectively improved their current

levels of cholesterol would be likely to engage in less frequent exercise. A repeatedmeasures ANOV A was conducted to assess whether or not there was a difference in
pmiicipants' repOlied practice of cardiovascular exercise three times a week or more.
Results indicated that, contrary to what was predicted, participants whose cholesterol
improved engaged in significantly more exercise after medication treatment (]vI = 2.98,
s.d. = .21) than before medication treatment (M= 2.59, s.d. = .20; F (1,45) = 5.56,p

<.05, eta2 = .11). As suggested by Cohen (1988) an eta above .31 is considered a large
2

effect size. This analysis revealed an eta of .33 (the square root of eta = .11) and is thus
considered a large effect size.
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Exererdse Habits
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Figure 12. Participants' levels of agreement with the following statements: "Since I
have been taking cholesterol-lowering medicine, I practice cardiovascular exercise
three time a week or more." "Before I began taking cholesterol-lowering medicine, I
practiced cardiovascular exercise three times a week or more." Where DA=disagree,
S/DS=somewhat disagree, N=neutrallunsure, S/A=somewhat agree, A=agree.

Hypothesis # 3
It was predicted that participants who have effectively improved their current
levels of cholesterol would be likely to engage in less frequent diet adherence. A
repeated-measures ANOVA was conducted to assess whether or not there was a
difference in pmiicipants' reported practice of good dietary practices. Results indicated
that, as predicted, participants whose cholesterol improved engaged in signiticantly less
diet adherence after medication treatment (}.If
treatment (M= 3.04, s.d. = .22; F (1,25)

2 .. 7, s.d. = .14) than before medication

12.84,p <.05, eta = .34). This analysis

revealed an eta of .58 (the square root of eta2

2

.34) and is thus considered a large effect
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SIze. This result should, however, be interpreted with caution because only 25 of the 47
respondents whose cholesterol improved completed all of the diet adherence questions
from before and after medication treatment.
Hypothesis # 4
It was predicted that participants on statin therapy who have improved levels of

cholesterol will possess a level of overconfident beliefs regarding the medications
protectiveness. Overconfidence was defined as a situation in which a subject responded
to any ofthe overconfidence variables as "somewhat agree," or "agree" (see Table 1).
The data reveal that 83% of the participants indicated they "somewhat disagree" or
"disagree" with the statements assessing overconfidence. The remaining 17% indicated
they were "neutral/unsure," or "somewhat agree."
Hypothesis # 5
It was predicted that beliefs about the causes of high cholesterol are related to diet
and exercise non-adherence and overconfident medication protection. Smprisingly,
individual beliefs are negatively related to exercise and diet non-adherence as well as to
medication overconfidence. Specifically, the variables "1 believe my cholesterol is
caused by poor diet" was negatively related to the variable "Since I have been talting
cholesterol-lowering medicine, I practice cardiovascular exercise three time a week or
more" (-.397**). Also, the variables "I believe my high cholesterol is caused by lack of
exercise" was negative related to the variable "Since I have been taking cholesterollowering medicine, I practice cardiovascular exercise three times a week or more"
(-.422**).
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Table 6
Interconelations for Personal Beliefs and Exercise and Diet non-adherence before and
after Statin medication therapy.

V43

V44

V45

Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Conelation
Sig. (2-tailed)
N

Diet b-4

Diet-non

V30

-.285
.120
31
.168
.365
31
.171
.358
.31

-.281
.092
37
.220
.191
37
.113
.505
37

.260
.078
47
-.267
.070
47
-.191
.198
47

V12
.147
.331
46
-.397**
.006
.46
-.422**
.003
46

V43 I believe my high cholesterol is caused by genetics
V44 I believe my high cholesterol is caused by poor diet
V45 I believe my high cholesterol is caused by the lack of exercise
Diet b-4 Diet non-adherence before medication (see table 3)
Diet-non Diet non-adherence after medication (see table 2)
V30 Before I began taking cholesterol lowering medicine, I practiced
cardiovascular exercise 3 times a week or more
V12 Since I began taking cholesterol lowering medicine, I practiced
cardiovascular exercise 3 times a week or more
Overcon Overconfidence variables (see table 1)

** Correlations are significant at the 0.01 level (2-tailed).

Overcon
-.077
.608
47
.013
.931
47
.270
.067
47

Statin Effects 57
CHAPTER 4
DISCUSSION
With obesity, hypertension, and coronary herui disease indicated as leading
conditions of American mOliality, a closer review of patient health-related behavior
involving the prevention of chronic disease seems wananted. However, to date there has
been scant literature available on the purely psychological effects that medical
interventions themselves elicit in patients. Psychologically related variables including
health and wellness beliefs, cognitive distOliions, overconfidence, logical fallacies, social
confonnity, nomlative social influence, various behavioral principles and the related
emotional correlates playa critical role in health maintenance and disease prevention;
they also may actually playa role in the exacerbation or the pathogeneses of celiain
diseases. Although medical and surgical interventions are indeed intended to improve the
functional capabilities of patients who struggle with a myriad of diseases, one must begin
to question if the actual interventions poses any psychological complications which
contraindicate, or stand in complete contrast, with the actual procedure.
For example, one intention of this study was to discover a relationship between
diet and exercise non-adherence of pruiicipants who are currently prescribed statin
medications to improve their cholesterol. Another intention of the study was to discover
a relationship between patient overconfidence regarding medication protectiveness and
respondents' eating and exercise behaviors. Although these hypotheses make strong
conceptual sense, practically they were difficult to validate accurately. That is, capturing
sincere, honest patient behavior appears practically impossible. Psychologists are very
well aware of, ruld control for, a respondent's capacity to provide more favorable results
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which are intended to cast a flattering review oftheir response pattern to the evaluator.
This notion of "faking good," or over-rep011ing desirable and virtuous qualities is a
common psychological effect of completing any psychological diagnostic instrument.
Psychologists understand, as agents of change themselves, that they can evoke
eounterintuitive or contraindicated behavior in their patients. In psychological terms this
may be called debasement, desirability, conformity, obedience to authority,
overconfidence or, in some cases properly named, the Hawthorne effect. If psychologists
are willing to understand, and subsequently admit this type of influence pursuant to their
interventions, it stands to reason physicians, including their interventions, will have
similar, if not identical influences.
The findings of this study are interesting because they offer support for some
hypotheses, and also reveal new insights beyond the intended scope of this study. Of
most notable concern, the findings did provide support for the hypothesis proposing that
individuals who experience an improvement in cholesterol levels after taking statin
medications begin to rcduce their adherence to healthy dietary habits (see Table 6). This
finding can lead to a number of speculations regarding how individuals think about the
positive effects of cholesterol-lowering medications. One possible explanation may
suggest that individuals on statin therapy who experience a significant drop in total
cholesterol levels and rapid improvement in lipid profiles may provide an impetus for
patient behavior to "regress to the mean." That is, it is plausible to suspect in the absence
of clear and convincing genetic evidence, that overeating, diet non-adherence, and the
excessive consumption of foods rich in trans-fatty acids are causally indicated in elevated
cholesterol levels. It therefore stands to reason that if diet non-adherence was the
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normative behavior before cholesterol medication, behavioral regression toward the mean
can explain some of the active diet non-adherence seen in participants who are on statin
therapy. Another possible explanation includes the phenomenon of overconfidence. The
data in this study reveal no significant difference between taking statin medication and
overconfidence, but other data including the prevalence of overweight and obese
paliicipants seems to provide evidence for some other factor moderating diet and exercise
non-adherence, possibly denial or apathy. However, overconfidence should not be
overlooked in future studies of similar interest. That is, social psychology purports the
overconfidence effect is a tendency for humans to be more confident about personal
beliefs, abilities, and behaviors than are actually accurate. With respect to statin therapy
and exercise non-adherence, overconfidence may result from reviewing the diminished
laboratory levels of total cholesterol, thereby creating a tendency to predict, or
overestimate the conective power of the medication and underestimate the need to
remain faithful to a healthy diet. The danger in this thinking may expose patients to an
inadequate understanding of total semm cholesterol as not being necessarily the best
reading of elevated lipids in the bloodstream. Together, high density lipoproteins, low
density lipoproteins, and triglicerides and their ratio to each other represent more accurate
lipid levels in the blood. Although total cholesterol may be reduced by significant
percentages, the appropriate ratios ofHDL's to LDL's to triglycerides may continue to be
misaligned. However, the initial interpretation of the reduced total cholesterol number
may provide enough evidence for some patients to non-adhere to healthful diets. Again,
although there was no statistical evidence for overconfidence in statin medication as a
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predictor of diet and exercise non-adherence, future researchers are encouraged to gather
a larger, more representative sample size.
Another discovery of this study revealed no significant difference found in the
amount of cardiovascular exercise practiced before beginning statin therapy and
concurrent with statin therapy (see Figure 10 and 11). However, a serendipitous
discovery revealed, a related, but discouraging finding. Results indicate that individual
personal health-related beliefs about the causes of high cholesterol were negatively
correlated at the 0.01 level of significance (-.397**) with the practice of cardiovascular
exercise three times a week or more. For example, participants who agreed with the
statement "I believe my cholesterol is caused by poor diet" were then likely to disagree
with the following variable: "Since I have been taking cholesterol lowering medicine, I
practice cardiovascular exercise three times a week or more." Interestingly, this finding
is in stark contrast to CUlTent medical beliefs. Also, data indicate individual personal
health beliefs about the lack of exercise causing elevated cholesterol were negatively
cOlTelated at the 0.01 level of significance (-.422**) with the practice of cardiovascular
exercise three times a week or more. Stated otherwise, paIiicipants who agreed with the
variable "I believe my cholesterol is caused by the lack of exercise" disagreed with the
variable "Since I have been taking cholesterol lowering medicine, I practice
cardiovascular exercise three times a week or more." Considering both negative
cOlTelations in light of the data in presented in Table 6, it would appear that paIiicipants
understand that genetic heritage is not entirely responsible for elevated cholesterol levels,
and that diet and exercise are effective ways to reduce it, but they appear unwilling to
change their lifestyles. Although this finding is not consistent with the construct of
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overconfidence, it may suggest a level of indifference or apathy regarding the use of
exercise and diet to control cholesterol. Again, these findings are in contrast to the
current medical belief, in which physicians are advised to educate their patients on the
benefits of exercise and a healthful diet.

Limitations of the Study
The results of this study should be interpreted in light of several potential
limitations. Generally, rating scale and survey data can be biased and be influenced by a
number of factors. Influences including the wording of statements, arrangement of
statements, and the content of the material itself may influence the subject to interpret the
statement differently. Also, in studies that employ surveys, questionnaires, or rating
scales, the subject may be motivated to respond in a fashion that is more socially
acceptable than are their true attitudes, beliefs, and behaviors. Although the statements
for the present study were designed to elicit agreement on a Likert scale and were created
in a fashion that was free of bias and of non-leading statements, survey data in general
are subject more frequently to the abovementioned methodological limitations.
Another foreseeable limitation of the cunent study includes the sample size and
population selected to paliicipate in the study. Although every effOli was made to ensure
a wide range of randomly selected participants, the samples were procured from a
particular geographic location, eastern Pennsylvania. This may provide an underrepresentation of various cultural and racial demographics. This poses a common and
general threat to the external validity of the study. The sample was biased for female
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paliicipants, and a larger sample size may have counterbalanced this unforeseen
tendency.
Also, the number of questions used in this study may have produce fatigue in
participants and caused them to respond randomly or in a hasty fashion. This was
evidenced by several incomplete surveys which needed to be discarded. The pace in
primary care medicine tends to be quick; a more focused survey with fewer items may
have been more expedient and quite possibly have influenced the results.
Last, the ANOV A used in hypothesis three did reveal statistical significance for a
negative change in healthy dietary habits following all improvement in cholesterol levels
pursuant to medication; however, the significance was small. A greater sample size may
help boost the power of this study and yield more favorable significance.

Implicationsfor Clinical Practice and Future Research
Although many factors will influence an individual's belief system about
medications, disease, and health-related behavior, the hypotheses for this study did
elucidate a number of implications regal"ding clinical practice. Initially, improvements in
the quantity and quality of physician education regarding the limitations of statin
medication can be adjusted accordingly, and simultaneous patient education regarding the
benefits of diet and exercise adherence can be further strengthened. Also, physicians can
fbrther benefit from the knowledge revealed in this study by becoming familiar with the
limitations of patient compliance and adjust their educational strategies in a more clearly
focused and direct fashion when presenting infol1uation to patients.
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Future researchers are encouraged to consider the methodological limitations of
this study and replicate future studies in light of the results provided herein. Continuing
to study overconfidence and the effects that it projects on health-related behaviors
continues to be an important construct, because overconfidence has been a well
established phenomenon in other areas of psychology. Developing fewer and more direct
statements to this population may yield favorable results. Also, expanding the sample
size may prove to be a prudent measure for future studies.

Conclusion
There is statistical evidence available to support the hypothesis that when statin
medicines improve cholesterol levels, and when improved levels are noticed, there is a
statistically signifIcant reduction in the adherence to healthy diet habits. Also,
participants appear to understand that genetics is not the only reason for elevated
cholesterol levels, with diet and exercise as reasonable ways to control for elevated
cholesterol. However, they do not adjust their lifestyles.
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APPENDIX A
Dear Potential Participant:
Barbara Golden, Psy.D., ABPP and Stephen Timchack, M.S. both of the
Philadelphia College of Osteopathic Medicine (PCOM) are conducting a research
study on people's thoughts regarding cholesterol-lowering medicines.
This study has been designed to maintain your privacy, and no one will be able
to find out who you are, or identify you from the answers that you report. You
will not be asked to provide any personal information. The questionnaires are
completely anonymous, but will be numbered to keep order if the packet
becomes unstapled. You will be asked to answer some basic questions and
mark your level of agreement with several statements regarding your diet
habits, health beliefs, and exercise frequency. It will take 15-20 minutes of
your time. If you agree to participate in this study, we ask that you fill out all
forms completely, and simply return them to the nurse or receptionist. You
may freely refuse to be in this study with absolutely no consequences. You can
decide to stop answering the survey at any time. Although, no personal
information will be asked, all the forms and questionnaires that you complete
will be kept secure and confidentiaL Only the researchers and members of the
Institutional Review Board at PCOM will be able to look at these records.
You will not receive any financial reimbursements for being in this research
study. You may not benefit directly from being in this research study.
However, other people in the future may benefit from what researchers learn
from this study. There is a possibility that you may, as a result of filling out the
questionnaires, find something out about yourself that may be potentially
distressing; however, this outcome is unlikely.
If you believe that you have suffered injury or illness during the course of this

study, you should contact the PCOM Office of Research and Sponsored
Programs at 215-871-6782.
If you have any questions about this research at any time, you can contact Dr.
Golden at (215) 871-6495. If you want to know more about Dr. Golden's

background, or the rights of research participants, you should call PCOM Office
of Research and Sponsored Programs at 215-871-6782.
Thank you very much for your time, help, and consideration in this study.
Sincerely,
Barbara A. Golden, Psy.D, ABPP
Associate Professor
Psychology
(215) 871-6511

Stephen M. Timchack, M.S.
Doctoral Candidate in Clinical
(570) 466-7015
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APPENDIXB

Demographic Survey

1. Has your physician diagnosed you with High Cholesterol?
a. YES
b. NO (if "NO" stop here and return survey)
2. If you are diagnosed with High Cholesterol, how long have
you had this condition?
a. Less than 1 year
b. 1-3 years
c. 4-6 years
d. 7-9 years
e. Over 10 years
f. Not applicable/don't know

3. Are you currently taking prescription tnedication(s) to help
control High Cholesterol?
a. Yes
b. No
4. If you are not taking prescription medicine(s) for high
cholesterol, do you follow a low-fat diet?
a. Yes
b. No
c. Not applicable
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5. What type of cholesterol nledication are you taking?
a. ZOCOR
b. LIPITOR
c. CRESTOR
d. VYTORIN
e. OTHER: - - - - - - - - - - - - - - - - - - - f. I do not know the name of my cholesterol medicine
g. I am not taking any medicines for high cholesterol
6. What is the dosage of your cholesterol nledication?
a. 10 nlg.
b. 20 mg
c. 30 mg.
d. 40 mg
e. Other: -----------------------f. I am not taking any nledicines for high cholesterol
g. I do not know the dose
7. How long have you been on this medicine?
a. 1 year or less
b. 2-4 years
c. 5-7 years
d. 8-10 years
e. more than 10 years
f. not applicable
8. Are you:
a. MALE
b. FEMALE
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9. Are you:
a. Black
b. White
c. Asian
d. Hispanic
e. Other:
10. How old are you?
a. 18-25
b. 26-35
c. 36-45
d. 46-55
e. 56-65
f. 66 or older
11. How often do you practice cardiovascular exercise (for
example, brisk walking or running)?
a. more than 3 tin1es weekly
b. 3 tilnes weekly
c. less than.3 tilnes weekly
d. I rarely practice cardiovascular training
12.What is your current weight? ~_~" _ _ __
13.How tall are you (in feet and inches)?_"
14.Do you follow a physician prescribed exercise progra111?
a. Yes, I follow it very closely
b. Yes, I follow it most of the time
c. No, I rarely follow it
d. No, I don't have a physician prescribed exercise
progran1

Statin Effects 73

I5.Do you follow a low-cholesterol (low fat) diet?
a. Yes, I follow my diet daily and honestly
b. Yes, I follow my diet, but sometimes I cheat
c. No, I don't usually follow a low fat diet
d. No, I don't Inlow what a low fat diet is
I6.High Cholesterol, that is untreated, may lead to which of the
following:
a. Heart attack and/or stroke
b. Depression
c. Anxiety
d. Gout
e. Stomach Ulcers
I 7.High Cholesterol can come from:
a. The foods I eat
b. My genetics (family history)
c. Getting too little physical exercise
d. All of the above
I8.Since I have been taking cholesterol-lowering medicine, my
physician has been
with my cholesterol level.
a. very satisfied
b. satisfied
c. very concerned
d. concerned
I9.My physician has told me that my cholesterol levels
have
since I have been on cholesterol-lowering
nledicine.
a. improved
b.· worsened
c. stayed the sanle

Statin Effects 74

20.Since I began taking cholesterol-lowering medicine, my
physician has
the dose of my cholesterollowering medicine.
a. increased
b. decreased
c. not changed
21. Which level of education best describes you:
a. Attended high school
b. Graduated high school
c. Some college
d. Graduated college
e. Attended graduate school
f. Graduated from graduate school
22. Which occupational category best describes your CUlTent
emploYlnent status:
a. Retired
b. Student
c. Management, Business or Financial
d. Science, Engineering or Computing
e. Healthcare PractitionerlProfessional
f. Other Professional
g. Technician
h. Sales
i. Adlninistrative Support
j. Construction or Trade Worker
k. Installation, Maintenance or Repair Worker
L Production or Manufacturing
m. Transportation
n. Laborer
o. Protective/Civil Service Worker
p. Other

Statin Effects 75

APPENDIXC

Survey of Health-Related Beliefs and Behaviors
DESCRIPTION: The following statements were designed to
understand your eating and exercise behaviors, as well as your healthrelated beliefs. Please consider each statement carefully and answer
honestly. If you are completely confused by a question or are
completely unsure how you feel, please shnply circle 3. There are
statements on both sides of the page, please do not skip any.
Please use the following scale to indicate your level of agreenlent
with each statement.

1. Since I've been taking cholesterol-lowering medicine, I can
eat anything I want.

1

2

3

4

5

2. Since I've been taking cholesterol-lowering medicine, I
watch the pOliion size of Iny food servings.
1

2

3

4

5
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3. I believe my cholesterol-lowering ll1edicine, without diet and
exercise, completely protects me from developing higher
cholesterol levels.
1

2

3

4

5

4. Since I take cholesterol-lowering medicine, exercising is not
that important.

1

2

3

4

5

5. Since I have been taking cholesterol-lowering medicine, I
feel less won-ied about choosing what I eat.

1

2

3

4

5

6. Since I have been taking the cholesterol-lowering medicine, I
eat "red" meat nlore than twice a week.

1

2

3

4

5

7. Since I have been taking cholesterol-lowering lTIedicine, I eat
lTIOre than three servings of dairy products daily.
1

2

3

4

5

8. Before I began taking cholesterol-lowering medicine, I ate
"red" meat more than twice a week.
1

2

3

4

5

Statin Effects 77

9. Taking cholesterol-lowering medicine regularly is nlore
important than Inaintaining a healthy diet.

1

2

3

4

5

10. Taking cholesterol-lowering nledicine regularly is more
important than exercise.
1

2

3

4

5

11. Since I take cholesterol-lowering medicine I can eat "fast
food" 2 or more tilnes a week.
1

2

3

4

5

12.Since I have been taking cholesterol-lowering nledicine, I
practice cardiovascular exercise 3 times a week or more.
1

2

3

4

5

13.1 believe my Doctor has prescribed a reasonable diet and
exercise plan for me.
1

2

3

4

5

14. I am taking cholesterol-lowering medicine to prevent the
possibility of a heart attack and/or stroke.

1

2

3

4

5

15. I trust the cholesterol-lowering nledicine I anl taking will
effectively lower my cholesterol without diet and exercise.

1

2

3

4

5

Statin Effects 78

16. If my cholesterol level continues to remain high while on
cholesterol-lowering medicine, I can have my dosage increased
and continue eating any of the foods I choose.

1

2

3

4

5

17. High Cholesterol COlnes entirely from genetics--diet and
exercise are not effective ways to reduce it.
1

2

3

4

5

18. Before I began taking cholesterol-lowering medicine, I ate
nlore than 3 servings of dairy product daily.
1

2

3

4

5

19. CUlTently, I eat five, or lnore, servings of fruits and
vegetables daily.
1

2

3

4

5

20. My Doctor has done a goodjob at educating me about the
dangers of High Cholesterol.

1

2

3

4

5

21. Taking cholesterol-lowering medicine allows me to
occasionally eat fattening food and over indulge.
1

2

3

4

5
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22. A healthy diet consists of plenty of flUits and vegetables,
whole grains, fish, and limited use of fats, processed
sugars, salt, and alcohol.
1

2

3

4

5

23. A healthy lifestyle consists of healthy eating, non-slnoking,
getting plenty of exercise, good sleep habits, good stress
Inanagement skills, and managing a healthy weight.
1

2

3

4

5

24. As described above, I have a healthy diet.
1

2

3

4

5

25. As described above, I have a healthy lifestyle.
1

2

3

4

5

26. Before I began taking cholesterol-lowering medicine, I ate
"fast food" 2 or more tilnes a week.

1

2

3

4

5

27. Before I began taking cholesterol-lowering Inedicine, I ate
Inore than 5 servings of fruits and vegetables daily.
1

2

3

4

5

28. Cunently, I eat "red" meat more than twice a week.
1

2

3

4

5
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29. Before I began taking cholesterol-lowering medicine, I was
not won-ied about nly diet.

1

2

3

4

5

30. Before I began taking cholesterol-lowering medicine, I
practiced cardiovascular exercise 3 times a week (for at
least 30 minutes) or more.

1

2

3

4

5

31. Before I began taking cholesterol-lowering medicine, I
watched the pOliion size of my food servings.

1

2

3

4

5

32. If I take care oflnyself, I can avoid illness.
1

2

3

4

5

33. Whenever I get sick it is because of something I've done or
not done.

1

2

3

4

5

34. Good health is largely a matter of good fortune.

1

2

3

4

5

35. No nlatter what I do, if I anl going to get sick I will get sick.

1

2

3

4

5

Statin Effects 81

36. Most people do not realize the extent to which their
illnesses are controlled by accidental happenings.

I

2

3

4

5

37. I can only do what my doctor tells me to do.
1

2

3

4

5

38. There are so many strange diseases around that you can
never know how or when you might pick one up.
1

2

3

4

5

39. When I feel ill, I lmow it's because I have not been getting
the proper exercise or eating right.
1

2

3

4

5

40. People who never get sick are just plain lucky.
1

2

3

4

5

41. People's ill health results froln their own carelessness.
1

2

3

4

5

42. I am directly responsible for my health.
1

2

3

4

5

43. I believe Iny high cholesterol is caused by genetics

I

2

3

4

5

44. I believe my cholesterol is caused by poor diet

I

2

3

4

5
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45. I believe my high cholesterol is caused by the lack of
exerClse.

1

2

3

4

5

